Malignant melanoma stage IV – Life with Disease

Go back

Stage IV malignant melanoma is a diagnosis that marks the cancer’s spread beyond its original location to distant parts of the body, requiring a thoughtful approach to care and a focus on what truly matters in each patient’s unique journey.

Understanding the Prognosis

When melanoma reaches stage IV, it means the cancer has traveled to distant organs or tissues far from where it first appeared. This is often described as metastatic melanoma, which means cancer cells have spread through the bloodstream or lymphatic system to places like the lungs, liver, brain, bones, or the digestive tract. The cancer may also appear in distant areas of the skin or in lymph nodes located far from the original tumor site.[1][2]

Understanding survival statistics can be difficult, but it helps to know what these numbers actually mean. According to the American Cancer Society, the 5-year survival rate for stage IV melanoma is approximately 35 percent. This means that about 35 out of every 100 people diagnosed with stage IV melanoma are still alive five years after their diagnosis.[6] However, these figures have been improving. Some cancer centers now report survival rates reaching 50 percent, largely thanks to newer treatment approaches that have become available in recent years.[8]

It’s important to understand that survival rates are estimates based on large groups of people. They cannot predict what will happen to any individual person. Many factors influence each person’s outcome, including their age, overall health, how well they respond to treatment, and which new therapies are available to them. Some patients with advanced melanoma have been able to control the disease for many years, and in certain cases, newer treatments have even led to long-term remission or what doctors consider a functional cure.[6][8]

The location where melanoma has spread also affects prognosis. Research shows that patients whose cancer has spread to the skin, lymph nodes, or gastrointestinal tract tend to have better outcomes, with a median survival of about 12.5 months. Those with cancer limited to the lungs have a median survival of approximately 8.3 months. Unfortunately, when melanoma reaches the liver, brain, or bones, the median survival drops to about 4.4 months.[10]

⚠️ Important
Survival statistics are based on data from the past and do not reflect the impact of the newest treatments. Many people diagnosed today have access to therapies that were not available when these statistics were calculated. This means your individual outlook may be better than older numbers suggest.

How the Disease Progresses Naturally

Without treatment, stage IV melanoma follows a progressive course as cancer cells continue to multiply and spread throughout the body. The melanoma cells that have already traveled to distant organs will continue to grow, forming new tumors in those locations. This can lead to increasing symptoms related to where the cancer has spread.[2]

The natural progression involves the cancer affecting more and more areas over time. If melanoma has spread to the lungs, breathing may become increasingly difficult. When it reaches the liver, that organ’s function gradually declines, affecting the body’s ability to process toxins and produce essential proteins. Brain metastases can cause neurological symptoms that worsen progressively. Bone metastases can lead to increasing pain and fractures.[2][6]

The disease progression typically accelerates over time. New metastases may appear in additional organs or body areas. The growing tumors can press on surrounding tissues, causing pain and interfering with normal organ function. As the cancer burden increases throughout the body, general symptoms like fatigue, weight loss, and weakness become more pronounced. The immune system becomes increasingly compromised, making the body more vulnerable to infections and other complications.[10]

Historically, before modern treatments became available, the 10-year survival rate for metastatic melanoma was less than 10 percent. The median survival was measured in months rather than years. This underscores why treatment is so important, as modern approaches can significantly alter this natural course.[10][12]

Possible Complications

Stage IV melanoma can lead to various complications depending on where the cancer has spread and how it affects different body systems. These complications can emerge unexpectedly and significantly impact quality of life, requiring careful monitoring and management.[2]

When melanoma spreads to the brain, it can cause serious neurological complications. These may include severe headaches, seizures, changes in vision, difficulty with balance and coordination, personality changes, or confusion. Brain metastases can also cause stroke-like symptoms if they press on critical areas. In some cases, melanoma can spread to the protective membranes around the brain and spinal cord, a condition called leptomeningeal metastasis, which can cause additional complications affecting thinking, movement, and sensation.[6]

Lung metastases can lead to breathing difficulties that gradually worsen over time. Patients may experience shortness of breath, persistent cough, chest pain, or coughing up blood. Large tumors in the lungs can block airways or cause fluid to accumulate around the lungs, making breathing even more challenging. This can severely limit physical activity and affect overall stamina.[3]

Liver involvement can cause the liver to stop working properly, leading to jaundice (yellowing of the skin and eyes), abdominal swelling from fluid accumulation, confusion due to toxin buildup, and easy bruising or bleeding. The liver plays so many vital roles that its dysfunction affects the entire body. Bone metastases can lead to severe pain, weakened bones that fracture easily, elevated calcium levels in the blood (which causes nausea, confusion, and kidney problems), and compression of the spinal cord if tumors grow in the spine.[2]

Gastrointestinal spread can cause abdominal pain, intestinal blockages, bleeding in the digestive tract leading to black stools or vomiting blood, and difficulty eating or keeping food down. Some patients develop sores that don’t heal, and these can become infected or cause significant discomfort.[6]

Treatment complications can also arise. Immunotherapy, which helps the immune system fight cancer, can sometimes cause the immune system to attack healthy tissues, leading to inflammation in the lungs, intestines, liver, or other organs. Targeted therapies may cause side effects like fever, fatigue, skin rashes, or joint pain. Surgery carries risks of infection, bleeding, and recovery challenges. Understanding these potential complications helps patients and families prepare and seek help promptly when problems arise.[2]

Impact on Daily Life

Living with stage IV melanoma affects nearly every aspect of daily life, creating physical, emotional, social, and practical challenges that patients and their families must navigate together. The disease and its treatments can change how people feel, what they can do, and how they relate to others.[16]

Physical symptoms can significantly limit daily activities. Fatigue is one of the most common and challenging symptoms, making even simple tasks feel exhausting. Many patients describe feeling tired in a way they’ve never experienced before—not the kind of tiredness that improves with rest, but a deep exhaustion that affects their ability to work, care for themselves, or participate in activities they once enjoyed. Pain from the cancer or its treatment can make movement difficult and interfere with sleep, creating a cycle that further drains energy.[6]

The emotional impact of a stage IV melanoma diagnosis can feel overwhelming. Many people experience anxiety, fear, sadness, anger, or all of these at different times. Worry about the future, treatment decisions, and how the illness will affect loved ones can feel constant. Some people struggle with feelings of guilt or question past decisions. These emotional responses are completely normal and expected when facing a serious illness. Depression is common and should be addressed, as it can affect how people feel physically and their ability to cope with treatment.[16]

Social relationships often change. Some people find that friends or family members don’t know what to say or do, which can lead to isolation. Others feel overwhelmed by people’s reactions or well-meaning but unwanted advice. Work relationships may shift, especially if physical symptoms or treatment schedules require reduced hours or medical leave. Some patients struggle with losing their professional identity or the financial security their job provided.[16]

Hobbies and recreational activities may need to be adjusted or temporarily set aside. Physical activities like sports, gardening, or travel may become more difficult due to fatigue or treatment schedules. However, experts emphasize that staying engaged with meaningful activities, even in modified forms, supports both physical and emotional wellbeing. Some people discover new interests that better fit their current circumstances.[16]

Financial concerns often add stress. Medical bills, insurance issues, lost income, and the cost of travel for treatment can create significant burdens. Many families worry about depleting savings or leaving debt behind. Practical tasks like managing appointments, organizing medications, and coordinating care can feel overwhelming, especially when feeling unwell.[21]

Despite these challenges, many patients find ways to maintain quality of life. Focusing on what can be controlled—such as maintaining healthy eating habits, staying as physically active as possible, managing stress through relaxation techniques, and staying connected with supportive people—can help. Many cancer centers offer resources including counseling, support groups, financial counseling, and practical assistance that can make the journey more manageable.[16]

⚠️ Important
You don’t have to face these challenges alone. Professional support from psychologists, social workers, and patient navigators can make a real difference. Many patients find that addressing the emotional and practical aspects of living with cancer is just as important as medical treatment in maintaining their wellbeing.

Support for Family Members and Clinical Trials

Family members and loved ones play a crucial role in supporting someone with stage IV melanoma, particularly when it comes to understanding treatment options like clinical trials. Their involvement can make a significant difference in helping patients navigate difficult decisions and access potentially beneficial treatments.[1]

Clinical trials are research studies that test new treatments or new combinations of existing treatments. For stage IV melanoma, clinical trials offer access to cutting-edge approaches that may prove more beneficial than currently approved therapies. Because melanoma treatment is advancing rapidly, with new drugs and combinations being developed constantly, many experts strongly encourage patients to consider participating in clinical trials, both at initial treatment and if the disease progresses.[1][7]

Families should understand that clinical trials are not just about benefiting the individual patient. Each trial contributes to advancing melanoma treatment for all future patients. Participation helps researchers understand which treatments work best, for whom they work, and how to use them most effectively. In the past decade, clinical trial participation has been instrumental in discovering the immunotherapy and targeted therapy treatments that have dramatically improved survival rates for melanoma patients.[7]

Family members can help in practical ways when it comes to clinical trials. They can assist with researching available trials, which involves looking at websites that list ongoing studies, contacting cancer centers that specialize in melanoma, and asking the patient’s medical team about appropriate trials. Understanding trial requirements is easier when two people are listening and asking questions. Families can help organize medical records, coordinate with trial coordinators, and attend appointments where trial information is discussed.[1]

Supporting a loved one through the decision-making process about clinical trials requires patience and understanding. Some patients feel hesitant about trials because they worry about receiving a placebo (inactive treatment) or experiencing unknown side effects. Family members should know that in cancer clinical trials, patients almost never receive placebos alone—they typically receive either the standard treatment or the standard treatment plus the experimental approach. Helping patients understand this can reduce anxiety about trial participation.[7]

Transportation and logistical support become especially important with clinical trials, as they often require frequent visits to specialized centers. Family members who can help with transportation, accompany patients to appointments, take notes during discussions with research staff, and help track symptoms or side effects provide invaluable support. Emotional support matters too—clinical trials can feel uncertain, and having someone to discuss concerns and feelings with makes the experience less isolating.[21]

Families should also understand the patient’s right to stop participating in a trial at any time if they choose to do so. This knowledge can reduce pressure and anxiety. Discussing what the patient values most—whether that’s trying every possible treatment, maintaining quality of life, spending time with family, or other priorities—helps everyone make decisions aligned with those values. These conversations, though difficult, are important for ensuring that treatment choices reflect what truly matters to the patient.[21]

Beyond clinical trials, families provide essential support by accompanying patients to regular appointments, helping manage medications, preparing nutritious meals, assisting with daily tasks when needed, and simply being present. Many family members benefit from joining support groups specifically for caregivers, where they can share experiences and coping strategies with others facing similar challenges. Taking care of themselves while caring for a loved one is not selfish—it’s necessary for sustaining the support they provide.[16]

💊 Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of this condition, based only on the provided sources:

  • Nivolumab (Opdivo) – An immunotherapy drug that helps the immune system recognize and attack cancer cells; used for treating metastatic melanoma
  • Pembrolizumab (Keytruda) – An immunotherapy drug that blocks proteins preventing the immune system from attacking cancer cells; approved for stage IV melanoma treatment
  • Ipilimumab (Yervoy) – An immunotherapy drug that enhances immune system response against melanoma; used alone or in combination with nivolumab
  • Dabrafenib (Tafinlar) – A targeted therapy drug for melanoma with BRAF gene mutations; typically used in combination with trametinib
  • Trametinib (Mekinist) – A targeted therapy drug used in combination with dabrafenib for BRAF-mutated melanoma
  • Vemurafenib (Zelboraf) – A targeted therapy drug that blocks the activity of mutated BRAF protein; used in combination with cobimetinib
  • Cobimetinib (Cotellic) – A targeted therapy drug used in combination with vemurafenib for melanoma treatment
  • Encorafenib (Braftovi) – A targeted therapy drug for BRAF-mutated melanoma; used in combination with binimetinib
  • Binimetinib (Mektovi) – A targeted therapy drug used in combination with encorafenib for BRAF-mutated melanoma
  • Aldesleukin (Proleukin, Interleukin-2) – An immunotherapy drug that stimulates immune system cells; approved by FDA for metastatic melanoma treatment
  • Talimogene laherparepvec (T-VEC) – A genetically modified oncolytic viral therapy injected directly into tumors for local treatment of unresectable melanoma lesions
  • Dacarbazine – A chemotherapy drug; FDA-approved since 1975 and remains a standard treatment option for metastatic melanoma

Ongoing Clinical Trials on Malignant melanoma stage IV

  • Study of INCB099280 for Patients with Advanced Solid Tumors Who Have Not Received Immunotherapy

    Not recruiting

    2 1 1
    Investigated drugs:
    Greece Hungary Romania

References

https://www.curemelanoma.org/about-melanoma/melanoma-staging/stage-4-melanoma

https://www.cancerresearchuk.org/about-cancer/melanoma/stages-types/stage-4

https://www.aimatmelanoma.org/stages-of-melanoma/stage-iv/

https://www.mskcc.org/cancer-care/types/melanoma/diagnosis/melanoma-stages

https://www.cancer.gov/publications/dictionaries/cancer-terms/def/stage-iv-melanoma

https://www.medicalnewstoday.com/articles/322765

https://www.curemelanoma.org/about-melanoma/melanoma-staging/stage-4-melanoma

https://www.mskcc.org/news/changing-melanoma-landscape-how-research-has-improved-outlook-people-advanced-disease

https://www.cancer.gov/types/skin/patient/melanoma-treatment-pdq

https://pmc.ncbi.nlm.nih.gov/articles/PMC2737459/

https://emedicine.medscape.com/article/2006810-overview

https://pubmed.ncbi.nlm.nih.gov/7805002/

https://cancer.ca/en/cancer-information/cancer-types/melanoma-skin/treatment/metastatic

https://www.cancer.gov/types/skin/hp/melanoma-treatment-pdq

https://www.curemelanoma.org/about-melanoma/melanoma-staging/stage-4-melanoma

https://www.curemelanoma.org/blog/practical-recommendations-for-surviving-and-thriving-despite-melanoma

https://www.cancerresearchuk.org/about-cancer/melanoma/stages-types/stage-4

https://www.mdanderson.org/cancerwise/stage-iv-melanoma-survivor–an-immunotherapy-drug-gave-me-my-life-back.h00-159385890.html

https://www.aimatmelanoma.org/stages-of-melanoma/stage-iv/

https://my.clevelandclinic.org/health/diseases/14391-melanoma

https://www.cancer.org/cancer/types/melanoma-skin-cancer/after-treatment/follow-up.html

FAQ

What does stage IV melanoma mean?

Stage IV melanoma means the cancer has spread (metastasized) from where it started to distant parts of the body, such as the lungs, liver, brain, bones, gastrointestinal tract, or distant areas of skin and lymph nodes. It is also called metastatic or advanced melanoma.

Can stage IV melanoma be cured?

While stage IV melanoma is considered an advanced cancer, newer treatment options have made long-term control and even cure possible in some cases. Some cancer centers report that newer immunotherapy treatments can control advanced melanoma for years and in some instances lead to what doctors consider a functional cure. However, outcomes vary greatly between individuals.

What is the survival rate for stage IV melanoma?

The 5-year survival rate for stage IV melanoma is approximately 35 percent according to the American Cancer Society, though some specialized cancer centers now report rates around 50 percent due to newer treatments. These are statistical averages and cannot predict individual outcomes, as many factors affect each person’s prognosis including their age, overall health, treatment response, and where the cancer has spread.

Should I consider participating in a clinical trial for stage IV melanoma?

Many melanoma experts strongly encourage patients with stage IV melanoma to consider clinical trials, both at initial treatment and if disease progresses. Clinical trials offer access to new treatments that may prove more beneficial than currently approved options. Because melanoma treatment is advancing rapidly with new drugs and combinations being developed, clinical trials can provide access to cutting-edge approaches while also helping advance treatment for all future patients.

How quickly does stage IV melanoma progress without treatment?

Without treatment, stage IV melanoma typically progresses over a period of months, with the cancer continuing to spread and grow in the areas where it has metastasized. Historically, before modern treatments, the median survival was measured in months rather than years, and the 10-year survival rate was less than 10 percent. The rate of progression can vary depending on where the cancer has spread and individual patient factors.

🎯 Key takeaways

  • Stage IV melanoma survival rates have doubled at some cancer centers over the past decade thanks to revolutionary immunotherapy and targeted therapy treatments
  • Where melanoma spreads matters significantly—metastases to skin or gastrointestinal tract have much better prognoses than spread to liver, brain, or bones
  • Clinical trials are strongly recommended for stage IV patients as they provide access to cutting-edge treatments and help advance care for all future patients
  • Treatment has expanded dramatically from just chemotherapy to now include immunotherapy, targeted therapy, surgery, radiation, and combination approaches
  • Survival statistics are estimates based on past data and don’t reflect the newest treatments available today, meaning individual outcomes may be better than historical numbers
  • Managing the emotional, social, and practical impacts of stage IV melanoma is as important as medical treatment for maintaining quality of life
  • Family support plays a crucial role in helping patients navigate treatment decisions, manage daily challenges, and access resources like clinical trials
  • Some patients with advanced melanoma achieve long-term disease control or even what doctors consider functional cure with newer checkpoint inhibitor immunotherapies